1.
Dhooria S, Agarwal R, Sehgal IS, Prasad KT, Muthu V, Garg M, et al. A real-world study of the tolerability and dosing of pirfenidone and its effect on survival in idiopathic pulmonary fibrosis: Pirfenidone dose and survival in IPF. Sarcoidosis Vasc Diffuse Lung Dis [Internet]. 2020 Jun. 30 [cited 2024 Nov. 26];37(2):148-57. Available from: https://mattioli1885journals.com/index.php/sarcoidosis/article/view/8718